We are live on
!
Find out more
MCM
Maryland Capital Management Portfolio holdings
AUM
$1.2B
1-Year Est. Return
18.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
-18.21%
3 Year Est. Return
+44.51%
5 Year Est. Return
+97.8%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$74.7M
(+5.3%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
2.98%
Top 10 Holdings %
Top 10 Hldgs %
37.39%
Holding
257
New
37
Increased
102
Reduced
85
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$25.7M |
| 2 |
Wingstop
WING
|
+$17.2M |
| 3 |
Target
TGT
|
+$9.75M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$9.61M |
| 5 |
Verisk Analytics
VRSK
|
+$5.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$12.7M |
| 2 |
PayPal
PYPL
|
+$5.95M |
| 3 |
Intel
INTC
|
+$5.55M |
| 4 |
Dominion Energy
D
|
+$3.81M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 15.85% |
| 3 | Consumer Discretionary | 12.27% |
| 4 | Financials | 11.28% |
| 5 | Communication Services | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Stryker
SYK
$134B
| $753K | 0.05% |
3,091
+35
| +1% | +$8.39K |
|
127
Vanguard Dividend Appreciation ETF
VIG
$114B
| $745K | 0.05% |
5,062
-470
| -8% | -$66.9K |
|
128
AdvisorShares Focused Equity ETF
CWS
$134M
| $744K | 0.05% |
16,650
-2,000
| -11% | -$87.7K |
|
129
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $743K | 0.05% |
6,826
+784
| +13% | +$87.6K |
|
130
Eaton
ETN
$178B
| $738K | 0.05% |
5,337
-465
| -8% | -$59.9K |
|
131
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $735K | 0.05% |
5,420
-135
| -2% | -$20.2K |
|
132
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.38B
| $724K | 0.05% |
5,650
-495
| -8% | -$62.9K |
|
133
iShares Core US Aggregate Bond ETF
AGG
$137B
| $687K | 0.05% |
6,032
+1,592
| +36% | +$184K |
|
|
AXON
134
Axon Enterprise
AXON
$51.7B
| $678K | 0.05% |
4,758
+1,488
| +46% | +$232K |
|
135
RH
RH
$3.46B
| $677K | 0.05% |
1,135
-100
| -8% | -$49.3K |
|
136
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $668K | 0.04% |
+4,160
| New | +$712K |
|
137
Chegg
CHGG
$92.8M
| $664K | 0.04% |
7,756
+2,633
| +51% | +$251K |
|
138
Yum! Brands
YUM
$39.5B
| $632K | 0.04% |
5,844
-1,054
| -15% | -$112K |
|
139
Nuveen Quality Municipal Income Fund
NAD
$2.75B
| $629K | 0.04% |
41,530
| – | – |
|
140
RTX Corp
RTX
$302B
| $602K | 0.04% |
+7,794
| New | +$569K |
|
141
Fox Factory Holding Corp
FOXF
$905M
| $601K | 0.04% |
4,728
+1,417
| +43% | +$183K |
|
|
142
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
| $598K | 0.04% |
3,225
-9,458
| -75% | -$1.71M |
|
143
US Bancorp
USB
$100B
| $596K | 0.04% |
10,784
-1,161
| -10% | -$58K |
|
144
Qualcomm
QCOM
$171B
| $571K | 0.04% |
4,305
+432
| +11% | +$62.3K |
|
145
Kratos Defense & Security Solutions
KTOS
$12B
| $565K | 0.04% |
20,703
+7,196
| +53% | +$202K |
|
146
United Parcel Service
UPS
$88.8B
| $556K | 0.04% |
3,270
+1,020
| +45% | +$165K |
|
147
Marriott International
MAR
$91.1B
| $546K | 0.04% |
3,689
-790
| -18% | -$108K |
|
148
Vanguard Morningstar Growth ETF
VUG
$228B
| $543K | 0.04% |
12,684
-516
| -4% | -$22.1K |
|
149
Bristol-Myers Squibb
BMY
$130B
| $542K | 0.04% |
8,586
-4,590
| -35% | -$286K |
|
150
Globant
GLOB
$1.68B
| $542K | 0.04% |
2,610
+435
| +20% | +$92.4K |
|
Similar funds
ACP
DWM
SIM
H6H
AIL
CCP
CL
RIG
Maryland Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Maryland Capital Management held 257 positions worth $1.5B, up 5.3% from $1.42B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Maryland Capital Management's Q1 2021 filing shows 37 new, 102 increased, 85 reduced and 16 closed positions. Its largest new stake was Edwards Lifesciences: 303,434 shares worth $25.4M. The largest sale was Lockheed Martin, an estimated $12.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Maryland Capital Management's largest Q1 2021 buy was Edwards Lifesciences: 303,434 shares worth $25.4M.
- Maryland Capital Management added most to Wingstop in Q1 2021, an estimated $17.2M increase.
- Maryland Capital Management's biggest Q1 2021 reduction was Lockheed Martin, cutting an estimated $12.7M.
- Maryland Capital Management fully exited Vanguard FTSE Pacific ETF in Q1 2021, selling an estimated $1.69M.
- Maryland Capital Management's ten largest holdings make up 37% of its $1.5B portfolio in Q1 2021.
- Maryland Capital Management opened 37 new positions and closed 16 in Q1 2021.
- Maryland Capital Management's portfolio value rose 5.3% quarter-over-quarter to $1.5B.
Based on Maryland Capital Management's 13F filing for Q1 2021, filed 11 May 2021.